Avanos Medical Statistics
Total Valuation
Avanos Medical has a market cap or net worth of $1.01 billion. The enterprise value is $1.15 billion.
| Market Cap | 1.01B |
| Enterprise Value | 1.15B |
Important Dates
The next estimated earnings date is Wednesday, August 7, 2024, before market open.
| Earnings Date | Aug 7, 2024 |
| Ex-Dividend Date | n/a |
Share Statistics
Avanos Medical has 45.90 million shares outstanding. The number of shares has decreased by -0.85% in one year.
| Shares Outstanding | 45.90M |
| Shares Change (YoY) | -0.85% |
| Shares Change (QoQ) | -0.48% |
| Owned by Insiders (%) | 2.86% |
| Owned by Institutions (%) | 96.93% |
| Float | 42.08M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | 14.33 |
| PS Ratio | 1.48 |
| Forward PS | 1.41 |
| PB Ratio | 0.82 |
| P/FCF Ratio | 75.90 |
| PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 546.82, with an EV/FCF ratio of 86.34.
| EV / Earnings | n/a |
| EV / Sales | 1.69 |
| EV / EBITDA | 546.82 |
| EV / EBIT | n/a |
| EV / FCF | 86.34 |
Financial Position
The company has a current ratio of 2.28, with a Debt / Equity ratio of 0.17.
| Current Ratio | 2.28 |
| Quick Ratio | 1.01 |
| Debt / Equity | 0.17 |
| Debt / EBITDA | 102.24 |
| Debt / FCF | 16.14 |
| Interest Coverage | -2.97 |
Financial Efficiency
Return on equity (ROE) is -5.10%.
| Return on Equity (ROE) | -5.10% |
| Return on Assets (ROA) | -3.70% |
| Return on Capital (ROIC) | n/a |
| Revenue Per Employee | $180,350 |
| Profits Per Employee | -$16,494 |
| Employee Count | 3,771 |
| Asset Turnover | 0.40 |
| Inventory Turnover | 1.62 |
Taxes
In the past 12 months, Avanos Medical has paid $4.30 million in taxes.
| Income Tax | 4.30M |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -15.91% in the last 52 weeks. The beta is 0.94, so Avanos Medical's price volatility has been similar to the market average.
| Beta (5Y) | 0.94 |
| 52-Week Price Change | -15.91% |
| 50-Day Moving Average | 20.02 |
| 200-Day Moving Average | 19.88 |
| Relative Strength Index (RSI) | 64.95 |
| Average Volume (20 Days) | 245,889 |
Short Selling Information
The latest short interest is 844,809, so 1.84% of the outstanding shares have been sold short.
| Short Interest | 844,809 |
| Short Previous Month | 1.05M |
| Short % of Shares Out | 1.84% |
| Short % of Float | 2.01% |
| Short Ratio (days to cover) | 3.75 |
Income Statement
In the last 12 months, Avanos Medical had revenue of $680.10 million and -$62.20 million in losses. Loss per share was -$1.33.
| Revenue | 680.10M |
| Gross Profit | 383.10M |
| Operating Income | 26.60M |
| Pretax Income | -57.90M |
| Net Income | -62.20M |
| EBITDA | 2.10M |
| EBIT | -43.30M |
| Loss Per Share | -$1.33 |
Balance Sheet
The company has $75.80 million in cash and $214.70 million in debt, giving a net cash position of -$138.90 million or -$3.03 per share.
| Cash & Cash Equivalents | 75.80M |
| Total Debt | 214.70M |
| Net Cash | -138.90M |
| Net Cash Per Share | -$3.03 |
| Equity (Book Value) | 1.23B |
| Book Value Per Share | 26.75 |
| Working Capital | 262.60M |
Cash Flow
In the last 12 months, operating cash flow was $31.20 million and capital expenditures -$17.90 million, giving a free cash flow of $13.30 million.
| Operating Cash Flow | 31.20M |
| Capital Expenditures | -17.90M |
| Free Cash Flow | 13.30M |
| FCF Per Share | $0.29 |
Margins
Gross margin is 56.33%, with operating and profit margins of 3.91% and -9.15%.
| Gross Margin | 56.33% |
| Operating Margin | 3.91% |
| Pretax Margin | -8.51% |
| Profit Margin | -9.15% |
| EBITDA Margin | 0.31% |
| EBIT Margin | -6.37% |
| FCF Margin | 1.96% |
Dividends & Yields
Avanos Medical does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | 0.85% |
| Shareholder Yield | 0.85% |
| Earnings Yield | -6.16% |
| FCF Yield | 1.32% |
Analyst Forecast
| Price Target | n/a |
| Price Target Difference | n/a |
| Analyst Consensus | Hold |
| Analyst Count | 2 |
| Revenue Growth Forecast (5Y) | n/a |
| EPS Growth Forecast (5Y) | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
Avanos Medical has an Altman Z-Score of 1.64 and a Piotroski F-Score of 5. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | 1.64 |
| Piotroski F-Score | 5 |